Identification of gene expression and abnormalities that define clinicopathological features of biliary tract carcinoma and their application in diagnosis and treatment
Identification of gene expression and abnormalities that define clinicopathological features of biliary tract carcinoma and their application in diagnosis and treatment
批准号:
17K08769
负责人:
Ojima Hidenori
金额:
$3.08万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2017
资助国家:
日本
项目状态:
已结题
起止时间:
2017-04-01 至 2020-03-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
肝胆膵領域に対する病理学的治療効果判定
肝胆胰区病理治疗效果判断
DOI:
--
发表时间:
2017
期刊:
病理と臨床
影响因子:
--
作者:
[尾島英知, 益田悠貴, 前原純樹, 上野彰久, 坂本康成]
通讯作者:
坂本康成
Gamma-Synuclein is a novel prognostic marker and promotes tumor cell migration in biliary tract carcinoma.
γ-突触核蛋白是一种新型预后标志物,可促进胆道癌中肿瘤细胞的迁移。
DOI:
--
发表时间:
2020
期刊:
影响因子:
--
作者:
[Yusuke Takemura, Hidenori Ojima, Go Oshima, Naoto Kubota, Masahiro Shinoda, Minoru Kitago, Hiroshi Yagi, Yuta Abe, Shutaro Hori, Yuki Masuda, Yoko Nishimura, Taizo Hibi, Michiie Sakamoto, Yuko Kitagawa]
通讯作者:
Yuko Kitagawa
SYNERGISTIC EFFECTS AND PHARMACOTHERAPEUTIC ACTIVITY OF GEMCITABINE AND CISPLATIN COMBINATION THERAPY IN BILIARY TRACT CANCER CELL LINES
吉西他滨与顺铂联合治疗对胆道癌细胞系的协同作用和药理活性
DOI:
--
发表时间:
2019
期刊:
影响因子:
--
作者:
[Yasunari Sakamoto, Seri Yamagishi, Takuji Okusaka, Hidenori Ojima.]
通讯作者:
Hidenori Ojima.
PI3K-mTOR pathway identified as a potential therapeutic target in biliary tract cancer using a newly established patient-derived cell panel assay
使用新建立的源自患者的细胞组检测将 PI3K-mTOR 通路确定为胆道癌的潜在治疗靶点
DOI:
10.1093/jjco/hyy011
发表时间:
2018
期刊:
Japanese Journal of Clinical Oncology
影响因子:
2.4
作者:
[Sakamoto Y., Yamagishi S., Tanizawa Y., Tajimi M., Okusaka T., Ojima H]
通讯作者:
Ojima H
病理形態学を基盤とした、胆道悪性腫瘍の進展に関わる分子機構の解明
基于病理形态学阐明胆道恶性肿瘤进展的分子机制
DOI:
--
发表时间:
2019
期刊:
影响因子:
--
作者:
[Yusuke Takemura, Hidenori Ojima, Go Oshima, Naoto Kubota, Masahiro Shinoda, Minoru Kitago, Hiroshi Yagi, Yuta Abe, Shutaro Hori, Yuki Masuda, Yoko Nishimura, Taizo Hibi, Michiie Sakamoto, Yuko Kitagawa, 尾島英知]
通讯作者:
尾島英知
共 7 条
Investigation of molecular mechanisms involved in carcinogenesis, proliferation and progression of billiary tract carcinoma and its application to clinical treatment
-
批准号:26460501
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.16万
-
财政年份:2014
-
负责人:Ojima Hidenori
-
依托单位:
海外基金